September 9th 2025
Ahead of the ESCRS congress and iNovation day, we go behind the scenes with Ciliatech founder Philippe Sourdille, MD, and president Olivier Benoit
360 degree trabeculectomy best way to treat congenital glaucoma
May 22nd 2008Using a microcatheter to perform 360° trabeculectomy is a safer and more consistent way to treat congenital glaucoma than traditional trabeculectomy, according to information presented at this year's meeting of the American Glaucoma Society (AGS).
Is cataract surgery the best way to lower IOP?
May 22nd 2008Extraction of cataracts lowers intraocular pressure (IOP) to normal levels in glaucoma patients, and may in fact be a better treatment option than combined surgery, according to a study presented at this year's meeting of the Italian Society of Ophthalmology.
Positive family history increases likelihood of visual field loss at presentation
May 16th 2008Patients with a positive family history of glaucoma are 10 times as likely to have visual field (VF) defects at the time of their diagnosis, according to a study published in the April issue of Clinical & Experimental Ophthalmology, the official Journal of the Royal Australian and New Zealand College of Ophthalmologists.
First preservative-free prostaglandin treatment approved
May 16th 2008Taflotan (tafluprost; Santen Oy), a benzalkonium chloride (BAK)-free prostaglandin analogue for the treatment of glaucoma, has received marketing authorization in Denmark and Germany, making it the first preservative-free prostaglandin eye drop to be approved.
Anterior juxtascleral depot of anecortave acetate reduces IOP significantly
May 9th 2008IOP can be reduced significantly by an anterior juxtascleral depot of anecortave acetate, according to study results presented on a poster at this year's meeting of the Association for Research in Vision and Ophthalmology.
Experimental nitric oxide-donating glaucoma treatment "effective", but Pfizer drops it
May 9th 2008PF-03187207, an experimental glaucoma treatment that was being developed by NicOx and Pfizer, has been shown in Phase II testing to be more effective in lowering IOP under certain circumstances than Pfizer's Xalatan (latanoprost) 0.005%, but it will not be advanced into Phase III testing, Pfizer has announced.
Eye health issues examined in Ophthalmology
May 9th 2008Three separate studies on eye health examine the role of antioxidant supplements, the relationship of visual acuity and mortality, and the causes of glaucoma in the May 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.
Peak IOP can be measured just as well with tilting as with water drinking
May 9th 2008A five-minute test in which a patient is tilted produces peak IOP detection levels comparable to standard water drinking tests, according to a poster presented at this year's meeting of the Association for Research in Vision and Ophthalmology.
CIGTS data: Large IOP reductions, initial trabeculectomy values validated
May 2nd 2008The Collaborative Initial Glaucoma Treatment Study (CIGTS) showed that substantially lowering IOP, whether through medication or surgery, can prevent vision loss. One of the major trials of recent years, CIGTS also showed that surgery was an effective first-line treatment and had important findings on quality of life.
Surgery for paediatric cataract entails increased glaucoma risk
May 2nd 2008Paediatric cataract surgery, particularly when performed in patients under the age of nine months, entails a substantial risk of post-surgical glaucoma, according to a study published in the January 2008 issue of Investigative Ophthalmology and Visual Science.
Eye drop contamination comes from bottle, not solution
April 18th 2008Bottles of infected eye drops are more likely to be contaminated with bacteria at the bottle tip and not within the solution, according to a study presented at this year's American Society of Cataract and Refractive Surgery (ASCRS) meeting.
Update and clinical pearls from the TVT study
April 18th 2008The Tube versus Trabeculectomy (TVT) Study found that nonvalved tube shunt surgery was more likely to maintain IOP control and avoid persistent hypotony and reoperation for glaucoma than trabeculectomy with mitomycin C (MMC) during the first year of follow-up.
Triamcinolone shown to raise IOP and cause gonioscopic changes
April 11th 2008Intraocular pressure (IOP) rises significantly and rapidly in eyes that have received an intravitreal injection of triamcinolone acetonide (IVTA), according to a study published in the March issue of the Journal of Ophthalmology.